Cost effectiveness and strategic planning (WHO-CHOICE)

WHO-CHOICE Interventions

Cardiovascular Disease

  • More Information
    Details on methods:
    Murray CJL, Lauer JA, Hutubessy RCW, Niessen L, Tomijima N, Rodgers A, Lawes CMM, Evans DB (March 2003)
    Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk
    The Lancet, 361: 717-725
  • Cost-Effectiveness Results


CODE DESCRIPTION
CVD-2 Salt reduction in food (voluntary): Voluntary co-operation of food manufacturers with government to decrease salt in processed food plus appropriate labelling
CVD-3 Salt reduction in food (enforced): Legislation to decrease salt content of processed foods plus appropriate labelling and enforcement
CVD-4 Health education through mass media to reduce cholesterol
CVD-5 Hypertension-lowering drug treatment (DRG) and education (ED) on lifestyle modification including dietary advice, delivered by physicians to individuals with systolic blood pressure (SBP) >160 mmHg.
CVD-6 As above with systolic BP> 140 mm Hg
CVD-7 Cholesterol-lowering drug treatment (statins) and education (ED) on lifestyle modification including dietary advice, delivered by physicians to individuals whose serum cholesterol concentration (CHOL) exceeds 220 mg/dl (5.7 mmol/l)
CVD-8 Statins and ED with CHOL >240 mg/dl (>6.2 mmol/l)
CVD-9 Treatment with triple therapy of hypertension lowering drug (beta-blocker), statins and aspirin for individuals with absolute risk of cardiovascular event of 5% in 10 years
CVD-10 Treatment with triple therapy of hypertension lowering drug, statins and aspirin for individuals with absolute risk of cardiovascular event of 15% in 10 years
CVD-11 Treatment with triple therapy of hypertension lowering drug, statins and aspirin for individuals with absolute risk of cardiovascular event of 25% in 10 years
CVD-12 Treatment with triple therapy of hypertension lowering drug, statins and aspirin for individuals with absolute risk of cardiovascular event of 35% in 10 years
CVD-13 Combination (CVD2 + CVD3)
CVD-14 Combination (CVD6 + CVD7)
CVD-15 Combination (CVD2 + CVD3 + CVD9)
CVD-16 Combination (CVD2 + CVD3 + CVD10)
CVD-17 Combination (CVD2 + CVD3 + CVD11)
CVD-18 Combination (CVD2 + CVD3 + CVD12)
Share